NOVEL IMMUNOTHERAPIES (CAR-T, BiTE)
CAR T-Cell Therapy–Related Cardiovascular Outcomes and Management, Systemic Disease or Direct Cardiotoxicity?
This review article provides an overview of the current understanding of potential cardiovascular toxicities associated with CD19-specific CAR T-cell therapies. It also details a proposed cardiac surveillance protocol for patients and discusses the future direction of cardio-oncology research related to CAR T-cell therapy.
JACC: CardioOncology
